Table 3.
Effect of PMTCT measurement strategy on performance ranking
| HIV testing, ART-PPO mother | HIV testing, CD4 testing, ART-PPO mother | ART-PPO mother | CD4 | HIV testing | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
||||||||||
| Rank | Clinic | Score | Rank | Clinic | Score | Rank | Clinic | Score | Rank | Clinic | Score | Rank | Clinic | Score |
| 1 | A | 0.958 | 1 | j | 0.745 | 1 | A | 0.947 | 1 | J | 0.611 | 1 | V | 1.00 |
| 2 | B | 0.941 | 2 | E | 0.723 | 2 | B | 0.923 | 2 | E | 0.442 | 2 | Q | 1.00 |
| 3 | C | 0.902 | 3 | A | 0.705 | 3 | C | 0.870 | 3 | N | 0.396 | 3 | Z | 1.00 |
| 4 | D | 0.864 | 4 | B | 0.627 | 4 | I | 0.796 | 4 | K | 0.310 | 4 | L | 1.00 |
| 5 | E | 0.863 | 5 | K | 0.620 | 5 | G | 0.788 | 5 | A | 0.200 | 5 | E | 1.00 |
| 6 | F | 0.862 | 6 | N | 0.620 | 6 | F | 0.788 | 6 | M | 0.165 | 6 | O | 1.00 |
| 7 | G | 0.857 | 7 | I | 0.610 | 7 | H | 0.782 | 7 | I | 0.124 | 7 | D | 1.00 |
| 8 | H | 0.856 | 8 | G | 0.603 | 8 | D | 0.727 | 8 | G | 0.096 | 8 | J | 1.00 |
| 9 | I | 0.853 | 9 | C | 0.601 | 9 | E | 0.726 | 9 | S | 0.078 | 9 | K | 0.98 |
| 10 | J | 0.813 | 10 | F | 0.586 | 10 | M | 0.647 | 10 | L | 0.056 | 10 | U | 0.98 |
| 11 | K | 0.776 | 11 | D | 0.576 | 11 | J | 0.628 | 11 | BB | 0.043 | 11 | A | 0.97 |
| 12 | L | 0.761 | 12 | H | 0.571 | 12 | K | 0.567 | 12 | F | 0.034 | 12 | S | 0.96 |
| 13 | M | 0.749 | 13 | M | 0.554 | 13 | N | 0.561 | 13 | R | 0.024 | 13 | B | 0.96 |
| 14 | N | 0.732 | 14 | L | 0.526 | 14 | P | 0.547 | 14 | AA | 0.007 | 14 | DD | 0.95 |
| 15 | O | 0.727 | 15 | S | 0.492 | 15 | T | 0.545 | 15 | H | 0.000 | 15 | Y | 0.95 |
| 16 | P | 0.726 | 16 | O | 0.484 | 16 | R | 0.540 | 16 | Q | 0.000 | 16 | F | 0.94 |
| 17 | Q | 0.714 | 17 | P | 0.484 | 17 | X | 0.524 | 17 | Z | 0.000 | 17 | C | 0.93 |
| 18 | R | 0.713 | 18 | R | 0.483 | 18 | L | 0.521 | 18 | B | 0.000 | 18 | H | 0.93 |
| 19 | S | 0.699 | 19 | Q | 0.476 | 19 | O | 0.453 | 19 | CC | 0.000 | 19 | G | 0.92 |
| 20 | T | 0.691 | 20 | T | 0.461 | 20 | S | 0.436 | 20 | O | 0.000 | 20 | I | 0.91 |
| 21 | U | 0.671 | 21 | U | 0.447 | 21 | Q | 0.429 | 21 | U | 0.000 | 21 | W | 0.91 |
| 22 | V | 0.669 | 22 | V | 0.446 | 22 | W | 0.396 | 22 | W | 0.000 | 22 | P | 0.91 |
| 23 | W | 0.652 | 23 | W | 0.434 | 23 | V | 0.367 | 23 | P | 0.000 | 23 | N | 0.90 |
| 24 | X | 0.640 | 24 | X | 0.427 | 24 | Y | 0.308 | 24 | T | 0.000 | 24 | AA | 0.90 |
| 25 | Y | 0.627 | 25 | Y | 0.418 | 25 | AA | 0.304 | 25 | X | 0.000 | 25 | CC | 0.89 |
| 26 | Z | 0.615 | 26 | Z | 0.410 | 26 | BB | 0.275 | 26 | Y | 0.000 | 26 | R | 0.89 |
| 27 | AA | 0.600 | 27 | AA | 0.402 | 27 | Z | 0.229 | 27 | DD | 0.000 | 27 | BB | 0.88 |
| 28 | BB | 0.579 | 28 | BB | 0.401 | 28 | CC | 0.095 | 28 | V | 0.000 | 28 | M | 0.85 |
| 29 | CC | 0.494 | 29 | CC | 0.329 | 29 | DD | 0.000 | 29 | C | 0.000 | 29 | T | 0.84 |
| 30 | DD | 0.477 | 30 | DD | 0.318 | 30 | V | 0.000 | 30 | D | 0.000 | 30 | X | 0.76 |
Dark grey: high performance; white: middle performance; spotted grey: low performance using dual HIV testing & ART-PPO mother ranking schema; HIV: human immunodeficiency virus; ART: antiretroviral therapy; PPO: prophylaxis; CD4: cluster of differentiation 4.